Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

10drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: belatacept ×

belatacept

This drug is selected. Its supporting articles are shown below.

Belatacept3

Articles mentioning belatacept

3 articles · page 1 of 1

4CPS-287 Conversion from tacrolimus to belatacept in kidney transplant recipients: real-world outcomes from a retrospective observational study

ejhpharm · abstract · 2026-03-18 · 8 matching annotations

97.2%

Belatacept tacrolimus national health system chronic graft dysfunction and loss Nephrology and Pharmacy departments

…ng them, graft survival was 94% (15/16) and two patient deaths. Belatacept persistence was 67% (n=16/24). Discontinuations occurred due to…

431 Immune checkpoint inhibitor for advanced cutaneous malignancies in organ transplant recipients: a case series from a single center experience

jitc · abstract · 2025-11-04 · 1 matching annotations

96.4%

sirolimus everolimus prednisone mycophenolate tacrolimus pembrolizumab belatacept cellcept cyclosporine cemiplimab+5 more

…g immunosuppressive regimens comprising various combinations of sirolimus, everolimus, prednisone, cellcept, cyclosporine, tacrolimus, be…

Kidney transplantation in congenital thrombotic thrombocytopaenic purpura: using recombinant ADAMTS13 to balance relapse and rejection

bmjcr · abstract · 2025-08-16 · 1 matching annotations

91.8%

belatacept mycophenolic acid calcineurin inhibitors recombinant ADAMTS13 Congenital thrombotic thrombocytopaenic purpura (cTTP)

…hange reduces the blood concentrations of mycophenolic acid and belatacept. We discuss a kidney allograft recipient with cTTP having repea…